相关实验视频

Updated: Jun 14, 2025

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

15.8K

对EBVSTs免疫疗法的响应者和不响应者之间的EBV蛋白特异性抗体反应差异

Yomani D Sarathkumara, Nathan W Van Bibber, Zhiwei Liu

    bioRxiv : the preprint server for biology
    |August 30, 2024
    PubMed
    概括

    针对埃普斯坦-巴尔病毒 (EBV) 的抗体可以预测EBV相关淋巴瘤的治疗反应. 对EBV蛋白质的特定IgG抗体在不响应EBV特异性T细胞 (EBVST) 免疫疗法的患者中较高.

    更多相关视频

    Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

    Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

    Published on: May 27, 2011

    17.2K
    Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines06:38

    Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

    Published on: November 8, 2011

    40.2K

    相关概念视频

    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    493